首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model.
【2h】

Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model.

机译:Zonula咬合毒素对肠道紧密连接的调节允许在动物模型中肠内注射胰岛素和其他大分子。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The intestinal epithelium represents the major barrier to absorption of orally administered drugs and peptides into the systemic circulation. Entry of molecules through the paracellular pathway is restricted by tight junctions. We have previously reported that these structures can be modulated by Zonula occludens toxin (Zot). In the present report, we show that Zot reversibly increases rabbit intestinal permeability to insulin by 72% (P = 0.034) and immunoglobulins by 52% (P = 0.04) in vitro. When tested in vivo, Zot induced a 10-fold increase of insulin absorption in both the rabbit jejunum and ileum, whereas no substantial changes were detected in the colon. Similar results were obtained with immunoglobulins, whereby Zot induced twofold and sixfold increases of IgG absorption in the jejunum and ileum, respectively. In diabetic rats, bioavailability of oral insulin coadministered with Zot was sufficient to lower serum glucose concentrations to levels comparable to those obtained after parenteral injection of the hormone. The survival time of diabetic animals chronically treated with oral insulin + Zot was comparable to that observed in parenterally treated rats. These studies offer an innovative strategy for the oral delivery of drugs and proteins normally not absorbed through the intestine.
机译:肠上皮是口服药物和肽吸收进入体循环的主要障碍。分子通过旁细胞途径进入受到紧密连接的限制。先前我们已经报道过,这些结构可以被闭合带状毒素(Zot)调节。在本报告中,我们显示Zot在体外可逆地增加了兔子对胰岛素的肠道渗透性72%(P = 0.034)和免疫球蛋白52%(P = 0.04)。当在体内进行测试时,Zot在家兔空肠和回肠中均诱导胰岛素吸收增加10倍,而在结肠中未检测到实质性变化。用免疫球蛋白获得了相似的结果,其中Zot诱导空肠和回肠中IgG的吸收分别增加了两倍和六倍。在糖尿病大鼠中,与Zot并用的口服胰岛素的生物利用度足以将血清葡萄糖浓度降低到与肠胃外注射激素后的水平相当的水平。口服胰岛素+ Zot长期治疗的糖尿病动物的生存时间与经肠胃外治疗的大鼠的生存时间相当。这些研究为口服递送通常不通过肠吸收的药物和蛋白质提供了创新的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号